| Title: |
LBA18 Overall survival (os) results from SOLAR-1, a phase III study of alpelisib (ALP) + fulvestrant (FUL) for hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (ABC) |
| Authors: |
André, F.; Ciruelos, E.M.; Juric, D.; Loibl, S.; Campone, M.; Mayer, I.; Rubovszky, G.; Yamashita, T.; Kaufman, B.; Lu, Y-S.; Inoue, K.; Papai, Z.; Takahashi, M.; Ghaznawi, F.; Mills, D.; Kaper, M.; Miller, M.; Conte, P.F.; Iwata, H.; Rugo, H.S. |
| Contributors: |
Novartis Pharmaceuticals Canada |
| Source: |
Annals of Oncology ; volume 31, page S1150-S1151 ; ISSN 0923-7534 |
| Publisher Information: |
Elsevier BV |
| Publication Year: |
2020 |
| Collection: |
ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| DOI: |
10.1016/j.annonc.2020.08.2246 |
| Availability: |
http://dx.doi.org/10.1016/j.annonc.2020.08.2246; https://api.elsevier.com/content/article/PII:S0923753420423282?httpAccept=text/xml; https://api.elsevier.com/content/article/PII:S0923753420423282?httpAccept=text/plain |
| Rights: |
https://www.elsevier.com/tdm/userlicense/1.0/ ; http://www.elsevier.com/open-access/userlicense/1.0/ |
| Accession Number: |
edsbas.1803315B |
| Database: |
BASE |